Mesabi Trust Press Releases

MSB 
$18.12
*  
0.33
1.85%
Get MSB Alerts
*Delayed - data as of Jan. 26, 2015  -  Find a broker to begin trading MSB now
Exchange: NYSE
Industry: Basic Industries
Community Rating:
View:    MSB Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Mesabi Trust Declares Distribution
1/16/2015 4:20:00 PM - Business Wire
▲1.80 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mesoblast Reports Positive 24 Month Results in Phase 2 Trial for Chronic Low Back Pain and Initiation of Phase 3 Program at JP Morgan Healthcare Conference
1/14/2015 6:13:00 PM - GlobeNewswire


Japanese Legislation Takes Effect for Expedited Approvals of Regenerative Medical Products
11/24/2014 8:07:00 PM - GlobeNewswire


Mesoblast's Phase 2 Trial Results In Chronic Low Back Pain Presented at North American Spine Society Annual Meeting
11/12/2014 6:36:00 PM - GlobeNewswire